Type 1 Diabetes

In Part 1 of this exclusive interview, Dr. Eckel discusses the new PCSK9 inhibitors, treating complicated patients, and the challenges of type 2.

I’ve been with many a person who has type 1, when the person is told if they would just eat, drink, or rub this potion on their body, or if they would just think a certain way, they would no longer have type 1 diabetes. When I see or hear this, I become very angry and protective. Today, a woman who has had type 1 diabetes for almost 30 years told me she went to an alternative healer for an essential oils treatment. The “healer” told her if she would rub the cinnamon oils on her ankles it would heal her diabetes. She asked me what I thought.

Does HbA1c variability predict retinopathy, nephropathy?

System shows significant improvement in HbA1c compared to current best therapy available.

Increasing need for insulin in mothers carrying multiple babies as compared to mothers carrying single.

Guest Post by David Kliff, Diabetic Investor Recently we learned the identity of the new British Prime Minister, Theresa May, who, according to a post on www.jdrf.org.uk, is a type 1 diabetic. The post states: “The Home Secretary Theresa May is on course to become the first prime minister who …

Part 2 of our ADA Rundown checks out the latest information on competing long-acting insulins, and the ongoing research into potential class effect benefits for cardiovascular outcomes: as data shows CV benefits for DPP-4 and SGLT-2 treatments, are GLP-1 treatments under pressure?

In this week's Homerun Slides, the cost of the current diabetes classification.

In this week's Homerun Slides, potential new treatment guidelines inspired by beta-cell-centric classification of diabetes.

In this week's Homerun Slides, changing the current classification of diabetes to reflect the beta-cell-centric approach.